Advertisement

Topics

Which Biopharmas Are Best Positioned For Five-Year Growth?

13:54 EST 1 Dec 2016 | SCRIP

Morningstar expects 229% revenue growth during the 2015-2020 period for BioMarin, far stronger than larger competitors. Virology powerhouse Gilead is...

      

Related Stories

 

Original Article: Which Biopharmas Are Best Positioned For Five-Year Growth?

NEXT ARTICLE

More From BioPortfolio on "Which Biopharmas Are Best Positioned For Five-Year Growth?"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...